Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation

PURPOSE: Approximately 5% of men were initially diagnosed with (also referred to as de novo) advanced stage prostate cancer and experience far poorer survival compared to men diagnosed with local or regionally advanced disease. Given the number of new therapies targeting metastatic and castrate‐resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beebe‐Dimmer, Jennifer L., Ruterbusch, Julie J., Cooney, Kathleen A., Bolton, Adam, Schwartz, Kendra, Schwartz, Ann G., Heath, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558501/
https://www.ncbi.nlm.nih.gov/pubmed/31094098
http://dx.doi.org/10.1002/cam4.2092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558501/
https://www.ncbi.nlm.nih.gov/pubmed/31094098
http://dx.doi.org/10.1002/cam4.2092

Ejemplares similares